Latest News and Press Releases

-- Zai Lab to Host Conference Call and Webcast Today at 8:30 a.m. ET-- SHANGHAI, China, May 02, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative...

WALTHAM, Mass. and SHANGHAI, China, April 25, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of...

SHANGHAI, China, April 24, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that members of the senior management team...

SHANGHAI, China, April 24, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that it will host a conference call and...

SHANGHAI, China, March 05, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced the appointment of Billy Cho as Chief...

SHANGHAI, China, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that Chief Executive Officer, Samantha Du,...

SHANGHAI, China, Jan. 03, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that Chief Executive Officer, Samantha Du,...

SHANGHAI, China, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, announced today that it has dosed the first patient in a...

NEW YORK, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) announces the closing of its U.S. initial public offering of 9,583,333 American depositary shares (“ADSs”) at a price of...

NEW YORK, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab”) announces the pricing of its U.S. initial public offering of American depositary shares (“ADSs”) (the “IPO”), raising gross...